Cocaine addiction: Current data for the clinician

被引:29
|
作者
Karila, Laurent [1 ]
Zarmdini, Rim [2 ]
Petit, Aymeric [3 ]
Lafaye, Genevieve [2 ]
Lowenstein, William [4 ]
Reynaud, Michel [2 ]
机构
[1] Univ Paris 11, Hop Univ Paul Brousse, AP HP, CEA Inserm U1000,Ctr Enseignement Rech & Traitmen, F-94800 Villejuif, France
[2] Univ Paris 11, Hop Univ Paul Brousse, AP HP, CEA Inserm U669,Ctr Enseignement Rech & Traitment, F-94800 Villejuif, France
[3] Univ Paris 07, Hop Bichat, AP HP, Serv Psychiat & Addictol, Paris, France
[4] SOS Addict, F-75016 Paris, France
来源
PRESSE MEDICALE | 2014年 / 43卷 / 01期
关键词
DRUG-USE; DEPENDENCE; RELIABILITY; VALIDITY;
D O I
10.1016/j.lpm.2013.01.069
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cocaine remains the second most commonly used illicit drug worldwide after cannabis. Observed levels of cocaine use among countries considerably vary. An increased cocaine use is recorded in the general European population. Cocaine addiction is a worldwide public health problem, which has somatic, psychiatric, socio-economic and judicial complications. It is a multifactorial disorder variable in its clinical manifestations and heritable. Compared to the general population, there is a high prevalence of somatic and psychiatric disorders among cocaine-dependent patients. There are predictable dose-related effects of pharmacological action of cocaine and effects which are uncommon, unrelated to dose and occur randomly in this population. The number of patients entering drug treatment for primary cocaine use has been increasing in Europe for several years. However, there is no specific pharmacotherapy with established efficacy for the treatment of cocaine addiction, nor is any medication approved by regulatory authorities for such treatment. Recent controlled clinical studies and laboratory studies have highlighted some very promising medications. The perfect therapeutic platform for abstinence initiation and relapse prevention of cocaine addiction is a combination of pharmacological treatments and behavioral treatments. Targeting somatic and psychiatric comorbidity is another way to use pharmacological treatments in addictions.
引用
收藏
页码:9 / 17
页数:9
相关论文
共 50 条
  • [21] MicroRNAs in Cocaine Addiction
    Kenny, Paul
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S96 - S96
  • [22] Therapy for cocaine addiction
    Goldberg, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (08): : 988 - 988
  • [23] Psychotherapy for cocaine addiction
    Van Horn, DHA
    Frank, AF
    PSYCHOLOGY OF ADDICTIVE BEHAVIORS, 1998, 12 (01) : 47 - 61
  • [24] Immunotherapy for cocaine addiction
    Landry, DW
    SCIENTIFIC AMERICAN, 1997, 276 (02) : 42 - 45
  • [25] Opiat and cocaine addiction
    Scherbaum, Norbert
    NERVENARZT, 2007, 78 : 163 - 163
  • [26] The Effect of Transcranial Direct Current Stimulation (tDCS) on Cocaine Addiction: A Narrative Review
    Chmiel, James
    Chojdak-Lukasiewicz, Justyna
    Leszek, Jerzy
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [27] A Neurocomputational Model for Cocaine Addiction
    Dezfouli, Amir
    Piray, Payam
    Keramati, Mohammad Mahdi
    Ekhtiari, Hamed
    Lucas, Caro
    Mokri, Azarakhsh
    NEURAL COMPUTATION, 2009, 21 (10) : 2869 - 2893
  • [28] The role of mitochondria in cocaine addiction
    Thornton, Claire
    Grad, Etty
    Yaka, Rami
    BIOCHEMICAL JOURNAL, 2021, 478 (04) : 749 - 764
  • [29] The Role of Acetylcholine in Cocaine Addiction
    Mark J Williams
    Bryon Adinoff
    Neuropsychopharmacology, 2008, 33 : 1779 - 1797
  • [30] COCAINE ADDICTION - ASSESSMENT AND INTERVENTION
    NUCKOLS, CC
    GREESON, J
    NURSING CLINICS OF NORTH AMERICA, 1989, 24 (01) : 33 - 43